Cargando…
The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
Papillary thyroid carcinoma (PTC), a common thyroid cancer (TC) subtype, rapidly increases in occurrence. MicroRNAs (miRNAs), which are non-coding small RNAs, have been demonstrated to play a role in cancer pathogenic mechanisms. Although miR-143 is involved in suppressing certain malignant tumor pr...
Autores principales: | Ding, Chao, Shi, Tiefeng, Wu, Gang, Man, Jianting, Han, Hongyu, Cui, Yunfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973723/ https://www.ncbi.nlm.nih.gov/pubmed/35213273 http://dx.doi.org/10.1080/21655979.2022.2044277 |
Ejemplares similares
-
Expression Profile and Clinical Significance of MicroRNAs in Papillary Thyroid Carcinoma
por: Peng, You, et al.
Publicado: (2014) -
BRAF(V600E) mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features
por: Shi, Chenlei, et al.
Publicado: (2020) -
The differential expression of microRNA-143,145 in endometriosis
por: Zheng, Bingbing, et al.
Publicado: (2014) -
MicroRNA-143/-145 in Cardiovascular Diseases
por: Zhao, Wang, et al.
Publicado: (2015) -
MicroRNA-495 Inhibits New Bone Regeneration via Targeting High Mobility Group AT-Hook 2 (HMGA2)
por: Tian, Zhao, et al.
Publicado: (2017)